RxDoctor Payments Data

Phillip Lim

Interventional Pain Medicine · Buena Park, CANPI 1023227154

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $82,419 of the $126,756 with a category attached, or 65.0%. Medtronic accounts for 68.8% of it on its own, with 48 other manufacturers making up the rest. Reporting peaked in 2019 at $30,341 and has fallen 70.2% since, to $9,029 in 2025. Among interventional pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$126,756in general payments, 2019–2025

Across 778 payments — averaging $162.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$87K
  • Boston Scientific$20K
  • Stryker$3K
  • Spinal Simplicity, LLC$3K
  • Saluda Medical Americas, Inc.$2K
  • Biohaven Pharmaceuticals, Inc.$1K
  • plus $11K from 43 others
$500in research payments, 2019–2025

Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertiflex, Inc.$500

What the payments were for

  • Consulting fees$3,2003%
  • Speaking & faculty fees$82,41965%
  • Travel & lodging$11,4029%
  • Food & beverage$29,68523%
  • Education$500%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,756 in reported general payments places this provider in the 95th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California

Medicare billing

Part B allowed, 2024
$350,834
Medicare patients
481
Services billed
7,291

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lidocaine34$6,246
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen227$4,006
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen83$2,006
Pregabalin51$1,394
Morphine Sulfate ErMorphine Sulfate33$988
Gabapentin76$867
Sodium Chloride0.9 % Sodium Chloride19$863
Celecoxib25$525
Oxycodone Hcl32$459
Methadone Hcl11$403
Acetaminophen-CodeineAcetaminophen With Codeine24$392
Phenytoin Sodium Extended12$370
Tramadol Hcl89$338
Cyclobenzaprine Hcl32$328
Baclofen22$288

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Buena Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →